CUSIP 75120L209 · who reports it, how much, and how much it matters to them
6 of the 720 hedge fund managers we track reported shares of Rallybio Corp (Nasdaq: RLYB) on Form 13F for 30 June 2026. Between them they reported USD 28m. The largest position belongs to Citadel Advisors, at USD 13m. The manager with the most riding on it is Rangeley Capital, where it is 1.5% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Citadel Advisors32 funds on PPLI.com | USD 13m | 0.0% |
| 2 | Viking Global Investors4 funds on PPLI.com | USD 8.4m | 0.0% |
| 3 | Renaissance Technologies13 funds on PPLI.com | USD 3.2m | 0.0% |
| 4 | Almitas Capital2 funds on PPLI.com | USD 1.9m | 0.5% |
| 5 | Rangeley Capital6 funds on PPLI.com | USD 1.7m | 1.5% |
| 6 | Two Sigma Investments35 funds on PPLI.com | USD 266,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Rangeley Capital | USD 1.7m | 1.5% |
| 2 | Almitas Capital | USD 1.9m | 0.5% |
| 3 | Viking Global Investors | USD 8.4m | 0.0% |
| 4 | Renaissance Technologies | USD 3.2m | 0.0% |
| 5 | Citadel Advisors | USD 13m | 0.0% |
| 6 | Two Sigma Investments | USD 266,000 | 0.0% |
Rallybio Corp trades under the symbol RLYB on the Nasdaq. Its CUSIP, the code used on Form 13F, is 75120L209.
6 of the 720 hedge fund managers PPLI.com tracks reported Rallybio Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 13m), Viking Global Investors (USD 8.4m), Renaissance Technologies (USD 3.2m), Almitas Capital (USD 1.9m) and Rangeley Capital (USD 1.7m).
6 managers in our coverage reported it, and between them they run 92 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Rangeley Capital, where the position was 1.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Rallybio Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.